Have your own idea? Try our Stock Screener
UPDATED Nov 26, 2024
Discover U.S. Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the NYSE and NASDAQ and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SIGA | US$7.03 | 12.3% | 33.9% | US$522.0m | n/a | PE5.9x | S7.5% | 8.5% | ||
OGN | US$15.79 | 8.2% | 39.7% | US$4.2b | US$22.38 | PE3.1x | E-7.1% | 7.1% | ||
PFE | US$25.77 | 2.7% | -13.2% | US$148.3b | US$32.55 | PE34.2x | E16.8% | 6.5% | ||
BMY | US$58.74 | 0.9% | 20.1% | US$119.2b | US$59.64 | PS2.5x | E49.9% | 4.1% | ||
PRGO | US$28.34 | 4.0% | -7.0% | US$3.9b | US$35.80 | PB0.8x | E63.8% | 3.9% | ||
VTRS | US$13.08 | 0.2% | 43.1% | US$15.9b | US$13.08 | PS1x | E53.5% | 3.7% | ||
ABBV | US$181.14 | 8.7% | 31.2% | US$312.9b | US$204.74 | PE63x | E28.1% | 3.6% | ||
GILD | US$91.35 | 4.1% | 22.6% | US$112.8b | US$97.20 | PE903.5x | E40.6% | 3.4% | ||
AMGN | US$280.01 | 0.02% | 5.5% | US$158.0b | US$331.67 | PE35.6x | E19.3% | 3.2% | ||
JNJ | US$154.52 | 1.0% | 1.9% | US$375.1b | US$174.89 | PE25.2x | E10.6% | 3.2% | ||
RPRX | US$26.29 | 1.1% | -3.0% | US$11.8b | US$41.53 | PE10.2x | E6.3% | 3.2% | ||
MRK | US$101.62 | 5.3% | 1.4% | US$255.9b | US$130.89 | PE21.2x | E15.6% | 3.0% | ||
QGEN | US$43.24 | 6.0% | 2.0% | US$9.6b | US$50.59 | PE103.4x | E34.4% | 3.0% | ||
ILMN | US$142.95 | 5.9% | 48.1% | US$22.8b | US$164.60 | PS5.2x | E70.4% | 2.2% | ||
PAHC | US$23.73 | -0.08% | 144.9% | US$977.8m | US$18.40 | PE55.2x | E60.0% | 2.0% | ||
ZTS | US$175.70 | 0.08% | -0.7% | US$80.6b | US$214.78 | PE32.6x | E9.9% | 1.0% | ||
A | US$134.37 | 6.9% | 7.7% | US$38.4b | US$148.76 | PE29.7x | E8.2% | 0.7% | ||
LLY | US$789.32 | 8.2% | 33.4% | US$679.8b | US$992.18 | PE84.9x | E29.2% | 0.7% | ||
MLAB | US$116.45 | 16.7% | 32.9% | US$617.1m | US$133.33 | PS2.8x | E134.3% | 0.5% | ||
DHR | US$236.58 | 2.5% | 8.1% | US$171.7b | US$290.13 | PE43.4x | E14.0% | 0.4% | ||
TECH | US$74.87 | 12.8% | 21.4% | US$11.8b | US$85.25 | PE78.9x | E21.2% | 0.4% | ||
BRKR | US$57.50 | 19.2% | -10.4% | US$8.9b | US$74.74 | PE28.6x | E32.3% | 0.3% | ||
TMO | US$512.98 | 0.8% | 5.6% | US$196.7b | US$653.94 | PE32x | E11.5% | 0.3% | ||
STVN | US$20.04 | 10.4% | -21.5% | US$5.4b | US$26.22 | PE45.5x | E20.3% | 0.3% |